Travel Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Composition (Mono Vaccines v/s Combination Vaccines), By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others), By Travel Type (Domestic v/s International) and By Region
The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of flu and rapid growth in the travel and tourism sector. Travel vaccines, also known as travel immunizations, are vaccine shots that protect travelers from serious illnesses. Vaccines work by exposing the body to germs of the disease it will protect against by enabling the production of antibodies. Besides, increasing awareness regarding the prevention of endemics and transnational infections and stringent advisories and regulations by health authorities to prevent the rise of infectious diseases are some of the factors driving the adoption of travel vaccines. The travel and tourism industry has witnessed a robust growth in recent years with the rise in disposable income of middle-class population across the world. Moreover, increasing trend of exploring different cultures, traditions, spiritualism, rural and ethnic living is propelling the adoption of travel vaccines. The COVID-19 pandemic has led to an increased emphasis on travel vaccines to avoid the spread of infections. As the public is becoming more aware and alert around the spread of infectious diseases, the demand for travel vaccine is expected to proliferate in the coming years. Growth in tourism activities have also led to the booming travel vaccine business for market players.
Stringent Advisories and Regulations by Health Authorities to Aid the Market Growth
Vaccination for diseases mentioned in the United States Department of Health & Human Services such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever is considered mandatory by some countries. These countries ask for mandatory vaccination proofs documented on an International Certification of Vaccination or Prophylaxis (ICVP) from travelers entering their country. Various countries' governments have implemented policies to prevent traveling citizens from travel-related infections. For instance, the National Health Services (NHS) organizes routine vaccination drives to prevent infectious diseases such as hepatitis A, typhoid, measles, mumps, yellow fever, among others. In addition, travelers coming for Hajj and Umrah in Saudi Arabia from various countries are required to show proof of vaccination for meningitis and seasonal influenza. Major countries such as the United States, Canada, Mexico, United Kingdom, Saudi Arabia, India, China, Japan, and Germany, among others, recommend travelers to be vaccinated for DPT. Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.
High Market Growth Potential in Emerging Nations
Rising personal disposable income of middle-class population in developing nations, owing to improving economic conditions, is increasing demand for travel and tourism. Travel and tourism is rapidly becoming a part of lifestyle for people in developing nations. Besides, growing awareness among population regarding various infections and disease that they could fall prey to while travelling to another country is boosting the travel vaccine market growth. Moreover, governments in developing regions are taking initiatives to create more awareness regarding infectious diseases, which is expected to fuel the growth of travel vaccines in the coming years.
Market Segmentation
The global travel vaccine market is segmented by composition, disease indication, travel type, and region. Based on composition, the market is divided into mono vaccines and combination vaccine. Based on disease indication, the market is divided into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and others. Based on travel type, the market is bifurcated into domestic and international. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is expected to hold a significant share in the global travel vaccine market, owing to rising incidences of infectious diseases and increased spending by population on travelling in the region.
Market Players
Key players operating in the global travel vaccine market are GlaxoSmithKline, plc., Sanofi S.A., Novartis International AG, Merck KGaA, Pfizer Inc., AstraZeneca Plc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, CSL Limited, Johnson & Johnson, among others.
Report Scope:
In this report, the global travel vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in global travel vaccine market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Stringent Advisories and Regulations by Health Authorities to Aid the Market Growth
Vaccination for diseases mentioned in the United States Department of Health & Human Services such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever is considered mandatory by some countries. These countries ask for mandatory vaccination proofs documented on an International Certification of Vaccination or Prophylaxis (ICVP) from travelers entering their country. Various countries' governments have implemented policies to prevent traveling citizens from travel-related infections. For instance, the National Health Services (NHS) organizes routine vaccination drives to prevent infectious diseases such as hepatitis A, typhoid, measles, mumps, yellow fever, among others. In addition, travelers coming for Hajj and Umrah in Saudi Arabia from various countries are required to show proof of vaccination for meningitis and seasonal influenza. Major countries such as the United States, Canada, Mexico, United Kingdom, Saudi Arabia, India, China, Japan, and Germany, among others, recommend travelers to be vaccinated for DPT. Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.
High Market Growth Potential in Emerging Nations
Rising personal disposable income of middle-class population in developing nations, owing to improving economic conditions, is increasing demand for travel and tourism. Travel and tourism is rapidly becoming a part of lifestyle for people in developing nations. Besides, growing awareness among population regarding various infections and disease that they could fall prey to while travelling to another country is boosting the travel vaccine market growth. Moreover, governments in developing regions are taking initiatives to create more awareness regarding infectious diseases, which is expected to fuel the growth of travel vaccines in the coming years.
Market Segmentation
The global travel vaccine market is segmented by composition, disease indication, travel type, and region. Based on composition, the market is divided into mono vaccines and combination vaccine. Based on disease indication, the market is divided into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and others. Based on travel type, the market is bifurcated into domestic and international. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is expected to hold a significant share in the global travel vaccine market, owing to rising incidences of infectious diseases and increased spending by population on travelling in the region.
Market Players
Key players operating in the global travel vaccine market are GlaxoSmithKline, plc., Sanofi S.A., Novartis International AG, Merck KGaA, Pfizer Inc., AstraZeneca Plc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, CSL Limited, Johnson & Johnson, among others.
Report Scope:
In this report, the global travel vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Travel Vaccine Market, By Composition:
- Mono Vaccines
- Combination Vaccines
- Travel Vaccine Market, By Disease Indication:
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
- Travel Vaccine Market, By Type:
- Domestic
- International
- Travel Vaccine Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- Singapore
- South Korea
- Europe & CIS
- Germany
- United Kingdom
- France
- Italy
- Spain
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Saudi Arabia
- Israel
- UAE
- Turkey
Company Profiles: Detailed analysis of the major companies present in global travel vaccine market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. IMPACT OF COVID-19 ON GLOBAL TRAVEL VACCINE MARKET
5. VOICE OF CUSTOMER
5.1. Travel Vaccination Awareness
5.2. Travel Vaccination, By Region
5.3. Travel Vaccination, By Travel Type
6. GLOBAL TRAVEL VACCINE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Composition (Mono Vaccines v/s Combination Vaccines)
6.2.2. By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)
6.2.3. By Travel Type (Domestic v/s International)
6.2.4. By Region
6.3. Product Market Map
7. NORTH AMERICA TRAVEL VACCINE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Composition
7.2.2. By Disease Indication
7.2.3. By Travel Type
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Travel Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Composition
7.3.1.2.2. By Disease Indication
7.3.1.2.3. By Travel Type
7.3.2. Mexico Travel Vaccine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Composition
7.3.2.2.2. By Disease Indication
7.3.2.2.3. By Travel Type
7.3.3. Canada Travel Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Composition
7.3.3.2.2. By Disease Indication
7.3.3.2.3. By Travel Type
8. EUROPE TRAVEL VACCINE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Composition
8.2.2. By Disease Indication
8.2.3. By Travel Type
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Travel Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Composition
8.3.1.2.2. By Disease Indication
8.3.1.2.3. By Travel Type
8.3.2. Germany Travel Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Composition
8.3.2.2.2. By Disease Indication
8.3.2.2.3. By Travel Type
8.3.3. United Kingdom Travel Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Composition
8.3.3.2.2. By Disease Indication
8.3.3.2.3. By Travel Type
8.3.4. Italy Travel Vaccine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Composition
8.3.4.2.2. By Disease Indication
8.3.4.2.3. By Travel Type
8.3.5. Spain Travel Vaccine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Composition
8.3.5.2.2. By Disease Indication
8.3.5.2.3. By Travel Type
9. ASIA-PACIFIC TRAVEL VACCINE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Composition
9.2.2. By Disease Indication
9.2.3. By Travel Type
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Travel Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Composition
9.3.1.2.2. By Disease Indication
9.3.1.2.3. By Travel Type
9.3.2. India Travel Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Composition
9.3.2.2.2. By Disease Indication
9.3.2.2.3. By Travel Type
9.3.3. South Korea Travel Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Composition
9.3.3.2.2. By Disease Indication
9.3.3.2.3. By Travel Type
9.3.4. Japan Travel Vaccine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Composition
9.3.4.2.2. By Disease Indication
9.3.4.2.3. By Travel Type
9.3.5. Australia Travel Vaccine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Composition
9.3.5.2.2. By Disease Indication
9.3.5.2.3. By Travel Type
9.3.6. Singapore Travel Vaccine Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Composition
9.3.6.2.2. By Disease Indication
9.3.6.2.3. By Travel Type
10. SOUTH AMERICA TRAVEL VACCINE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Composition
10.2.2. By Disease Indication
10.2.3. By Travel Type
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Travel Vaccine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Composition
10.3.1.2.2. By Disease Indication
10.3.1.2.3. By Travel Type
10.3.2. Argentina Travel Vaccine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Composition
10.3.2.2.2. By Disease Indication
10.3.2.2.3. By Travel Type
10.3.3. Colombia Travel Vaccine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Composition
10.3.3.2.2. By Disease Indication
10.3.3.2.3. By Travel Type
11. MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Composition
11.2.2. By Disease Indication
11.2.3. By Travel Type
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Travel Vaccine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Composition
11.3.1.2.2. By Disease Indication
11.3.1.2.3. By Travel Type
11.3.2. Saudi Arabia Travel Vaccine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Composition
11.3.2.2.2. By Disease Indication
11.3.2.2.3. By Travel Type
11.3.3. UAE Travel Vaccine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Composition
11.3.3.2.2. By Disease Indication
11.3.3.2.3. By Travel Type
11.3.4. Israel Travel Vaccine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Composition
11.3.4.2.2. By Disease Indication
11.3.4.2.3. By Travel Type
11.3.5. Turkey Travel Vaccine Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Composition
11.3.5.2.2. By Disease Indication
11.3.5.2.3. By Travel Type
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE (INCLUSIVE OF SWOT ANALYSIS OF PLAYERS PROFILED)
14.1. GlaxoSmithKline, plc.
14.2. Sanofi S.A.
14.3. Novartis International AG
14.4. Merck KGaA
14.5. Pfizer Inc.
14.6. AstraZeneca Plc.
14.7. Abbott Laboratories, Inc.
14.8. F. Hoffmann-La Roche AG
14.9. CSL Limited
14.10. Johnson & Johnson
15. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. IMPACT OF COVID-19 ON GLOBAL TRAVEL VACCINE MARKET
5. VOICE OF CUSTOMER
5.1. Travel Vaccination Awareness
5.2. Travel Vaccination, By Region
5.3. Travel Vaccination, By Travel Type
6. GLOBAL TRAVEL VACCINE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Composition (Mono Vaccines v/s Combination Vaccines)
6.2.2. By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)
6.2.3. By Travel Type (Domestic v/s International)
6.2.4. By Region
6.3. Product Market Map
7. NORTH AMERICA TRAVEL VACCINE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Composition
7.2.2. By Disease Indication
7.2.3. By Travel Type
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Travel Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Composition
7.3.1.2.2. By Disease Indication
7.3.1.2.3. By Travel Type
7.3.2. Mexico Travel Vaccine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Composition
7.3.2.2.2. By Disease Indication
7.3.2.2.3. By Travel Type
7.3.3. Canada Travel Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Composition
7.3.3.2.2. By Disease Indication
7.3.3.2.3. By Travel Type
8. EUROPE TRAVEL VACCINE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Composition
8.2.2. By Disease Indication
8.2.3. By Travel Type
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Travel Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Composition
8.3.1.2.2. By Disease Indication
8.3.1.2.3. By Travel Type
8.3.2. Germany Travel Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Composition
8.3.2.2.2. By Disease Indication
8.3.2.2.3. By Travel Type
8.3.3. United Kingdom Travel Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Composition
8.3.3.2.2. By Disease Indication
8.3.3.2.3. By Travel Type
8.3.4. Italy Travel Vaccine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Composition
8.3.4.2.2. By Disease Indication
8.3.4.2.3. By Travel Type
8.3.5. Spain Travel Vaccine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Composition
8.3.5.2.2. By Disease Indication
8.3.5.2.3. By Travel Type
9. ASIA-PACIFIC TRAVEL VACCINE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Composition
9.2.2. By Disease Indication
9.2.3. By Travel Type
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Travel Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Composition
9.3.1.2.2. By Disease Indication
9.3.1.2.3. By Travel Type
9.3.2. India Travel Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Composition
9.3.2.2.2. By Disease Indication
9.3.2.2.3. By Travel Type
9.3.3. South Korea Travel Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Composition
9.3.3.2.2. By Disease Indication
9.3.3.2.3. By Travel Type
9.3.4. Japan Travel Vaccine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Composition
9.3.4.2.2. By Disease Indication
9.3.4.2.3. By Travel Type
9.3.5. Australia Travel Vaccine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Composition
9.3.5.2.2. By Disease Indication
9.3.5.2.3. By Travel Type
9.3.6. Singapore Travel Vaccine Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Composition
9.3.6.2.2. By Disease Indication
9.3.6.2.3. By Travel Type
10. SOUTH AMERICA TRAVEL VACCINE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Composition
10.2.2. By Disease Indication
10.2.3. By Travel Type
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Travel Vaccine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Composition
10.3.1.2.2. By Disease Indication
10.3.1.2.3. By Travel Type
10.3.2. Argentina Travel Vaccine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Composition
10.3.2.2.2. By Disease Indication
10.3.2.2.3. By Travel Type
10.3.3. Colombia Travel Vaccine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Composition
10.3.3.2.2. By Disease Indication
10.3.3.2.3. By Travel Type
11. MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Composition
11.2.2. By Disease Indication
11.2.3. By Travel Type
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Travel Vaccine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Composition
11.3.1.2.2. By Disease Indication
11.3.1.2.3. By Travel Type
11.3.2. Saudi Arabia Travel Vaccine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Composition
11.3.2.2.2. By Disease Indication
11.3.2.2.3. By Travel Type
11.3.3. UAE Travel Vaccine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Composition
11.3.3.2.2. By Disease Indication
11.3.3.2.3. By Travel Type
11.3.4. Israel Travel Vaccine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Composition
11.3.4.2.2. By Disease Indication
11.3.4.2.3. By Travel Type
11.3.5. Turkey Travel Vaccine Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Composition
11.3.5.2.2. By Disease Indication
11.3.5.2.3. By Travel Type
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE (INCLUSIVE OF SWOT ANALYSIS OF PLAYERS PROFILED)
14.1. GlaxoSmithKline, plc.
14.2. Sanofi S.A.
14.3. Novartis International AG
14.4. Merck KGaA
14.5. Pfizer Inc.
14.6. AstraZeneca Plc.
14.7. Abbott Laboratories, Inc.
14.8. F. Hoffmann-La Roche AG
14.9. CSL Limited
14.10. Johnson & Johnson
15. STRATEGIC RECOMMENDATIONS
